MHLW Warns Of Side Effects For Two More Influenza Drugs
This article was originally published in PharmAsia News
Besides Tamiflu, whose side effects had been previously cautioned, Japan is calling attention to the occurrence of abnormal behaviors in minors taking influenza treatments GlaxoSmithKline's Relenza (zanamivir) and amantadine. Japan's Ministry of Health, Labor and Welfare has received reports of neuropsychiatric events, including patients jumping out of balconies. On Jan. 29, MHLW revised the drugs' package inserts and called physicians' attentions to these side effects. MHLW asked for parental monitoring for at least two days after a minor takes the flu drugs. (Click here for more-Japanese language
You may also be interested in...
Given its ever-growing role as a critical component of the global biopharma industry, you can’t afford not to be up to speed on Asia. This biweekly selection of insights from our experienced on-the-ground team will help.
Becton Dickinson will spend $1.2bn over the next four years to improve its drug-delivery device manufacturing capabilities. See what Eric Borin, president of BD, said about it here.
Pfizer is producing vaccine doses at scale now that it has buttoned down the manufacturing process.